Abbott Laboratories ABT

101.29 0.22 0.22% as of 25 Sep
Market cap
$174.8B
P/E
32.8×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
10.58% 12.33% 12.96% 30.62%

+8 more TTM periods

ROA
5.62% 6.54% 7.76% 17.63%
ROIC
5.83% 6.06% 8.87% 8.54%
Return on Tangible Assets
27.80% 32.17% 30.61% 64.23%
Average Days of Receivables
67.37 66.39 65.29 67.75
Free Cash Flow per Share
4.50 4.23 4.25 3.97
Free Cash Flow
7,824.00 7,378.00 7,395.00 6,917.00
Capital Expenditures
(2,081.00) (2,086.00) (2,171.00) (2,202.00)
Piotroski F-Score
4.00 4.00 5.00 6.00
Other line items
Cash ROIC
11.01% 10.06% 12.82% 12.68%
Accounts Receivable Turnover
5.62 5.81 5.97 5.77
Accounts Payable Turnover
4.44 4.44 4.58 4.74
Inventory Turnover
2.83 2.90 3.05 2.86
Average Days of Payables
86.57 86.51 80.11 77.82
Days of Inventory on Hand
132.10 129.22 122.58 126.61
Tax Rate
(0.28) (0.23) (0.23) 0.72
Research and Development Expense of Revenue
6.78% 6.63% 6.64% 6.74%
Selling, General and Administrative Expense of Revenue
29.93% 28.83% 27.82% 27.62%
Share Based Compensation of Revenue
1.54% 1.53% 1.50% 1.51%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
1.83 1.51 1.47 0.65
Depreciation/Fixed assets
0.27 0.26 0.26 0.27
Capex/Depreciation
(0.60) (0.66) (0.70) (0.70)
Revenue per Share
26.77 25.90 25.46 25.17
Operating CF per Share
5.69 5.43 5.49 5.23
Capex per Share
(1.20) (1.20) (1.25) (1.26)
Capex to Sales
0.04 0.05 0.05 0.05
Net Profit Margin
11.65% 13.91% 14.72% 31.88%

Fold the line items

Columns are period end dates